Elsevier

Vaccine

Volume 38, Issue 48, 10 November 2020, Pages 7588-7595
Vaccine

Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry

https://doi.org/10.1016/j.vaccine.2020.10.034Get rights and content
Under a Creative Commons license
open access

Highlights

  • Understanding uncertainty in the COVID-19 pandemic is a priority for the industry.

  • Policy and population behavioral affect risk management in the short/mid-term.

  • Information around natural history unknowns will guide long-term risk management.

  • Our framework allows risk management and risk-sharing strategies discussions.

Cited by (0)